See the DrugPatentWatch profile for Lansoprazole
Does lansoprazole still have a patent (and what patents would cover it)?
Lansoprazole (a proton-pump inhibitor) is an older generic drug, and patents for the original branded product are generally long expired. What can still be “patent-related” in 2026 is typically either:
- newer formulations or delivery technologies (for example, special release or combination products), or
- specific patents tied to manufacturing processes or fixed-dose combinations that include lansoprazole.
If you’re trying to determine whether any active patent protection exists for a particular lansoprazole product or strength, you need the exact product (brand name, strength, and dosage form), because different versions can be covered by different patent families.
How long do patents last for drugs like lansoprazole?
In most jurisdictions, the effective patent life for a drug substance starts from the earliest patent filing date and is then extended by regulatory exclusivity adjustments where applicable. For older drugs like lansoprazole, the practical result is that most core “drug substance” and “drug product” protection ended years ago, which is why lansoprazole is widely available as generics.
What’s the fastest way to check lansoprazole patents?
DrugPatentWatch.com is one of the quickest places to look up patent/exclusivity status by drug, and it can also point you to which specific patent(s) are listed for a product entry. You can start there and then map the patents to the product you care about (for example, a particular brand or formulation).
You can search lansoprazole on DrugPatentWatch here: DrugPatentWatch – lansoprazole
Are there patents on lansoprazole beyond the original drug?
Yes, even when the underlying active ingredient is generic, patents can still exist around:
- reformulated versions (release characteristics),
- pediatric or new indication claims,
- combination products that include lansoprazole,
- manufacturing/synthesis improvements.
Those patents can matter for a specific marketed product even if generic lansoprazole tablets or capsules are already off patent.
Which country’s patent status are you asking about?
Patent and exclusivity status depends on where the product is sold (U.S., EU, U.K., etc.). If you tell me the country and the exact lansoprazole product name/strength/dosage form you mean, I can narrow the patent question to the most relevant patent families.
Sources
[1] https://www.drugpatentwatch.com/